Ashley Graham

PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas

David S.P. Tan, Maryou B. Lambros, Sydonia Rayter et al. · Clinical Cancer Research · 2009 · 166 citations

Medicine, Cancer Biology, Molecular Biology +16

Tissue microarray technology in the routine assessment of HER‐2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence <i>in situ</i> hybridization

Ashley Graham, Dana Faratian, Frances Rae et al. · Histopathology · 2008 · 32 citations · Full text

Medicine, Oncology, Breast Oncology +16

Factors affecting the number of sentinel lymph nodes removed in patients having surgery for breast cancer

J. Michael Dixon, Julia Grewar, Dominique Twelves et al. · Breast Cancer Research and Treatment · 2020 · 18 citations · Full text

Medicine, Oncology, Surgery +12

Rapid screening of tissue microarrays for Her‐2 fluorescence <i>in situ</i> hybridization testing is an accurate, efficient and economic method of providing an entirely <i>in situ</i> hybridization‐based Her‐2 testing service

Dana Faratian, Ashley Graham, Frances Rae et al. · Histopathology · 2009 · 11 citations · Full text

Medicine, Oncology, Pathology +16

Occult disease in reduction mammoplasties and prophylactic mastectomies

Angheliki Nomikos, Ehab Husain, Ashley Graham · The Breast Journal · 2019 · 10 citations

Medicine, Pathology, Surgery +17